TLR4 is a negative regulator in noninfectious lung inflammation
- PMID: 20357263
- PMCID: PMC10733842
- DOI: 10.4049/jimmunol.1000009
TLR4 is a negative regulator in noninfectious lung inflammation
Abstract
Low m.w. hyaluronan (LMW HA) has been shown to elicit the expression of proinflammatory cytokines and chemokines in various cells in vitro. However, the effects of this molecule in vivo are unknown. In this study, we report that intratracheal administration of LMW HA (200 kDa) causes inflammation in mouse lung. A lack of TLR4 is associated with even stronger inflammatory response in the lung as shown by increased neutrophil counts and elevated cytokine and chemokine concentrations. We also demonstrate that TLR4 anti-inflammatory signaling is dependent upon a MyD88-independent pathway. TLR4-mediated IL-1R antagonist production plays a negative regulatory role in LMW HA (200 kDa) induced lung inflammation. These data provide a molecular level explanation for the function of TLR4 in LMW HA (200 kDa)-induced lung inflammation, as inhibition of the beta form of pro-IL-1 promotes an anti-inflammatory response.
Conflict of interest statement
Disclosures
The authors have no financial conflicts of interest.
Figures
References
-
- O’Neill LA 2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226: 10–18. - PubMed
-
- Miyake K 2007. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol. 19: 3–10. - PubMed
-
- Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, and Gallo RL. 2004. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279: 17079–17084. - PubMed
-
- Akira S, Uematsu S, and Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124: 783–801. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
